About Mitochondrial Disease and Specialties – Part 2

The Mitochondrial Medicine Society (MMS) and the United Mitochondrial Disease Foundation are pleased to offer curriculum to provide clinicians an opportunity to learn more about mitochondrial disease as well as earn continuing medical education credits.

COURSE DESCRIPTION

The United Mitochondrial Disease Foundation and PeerPoint Medical Education Institute have joined efforts to sponsor and organize CME-accredited VIRTUAL courses as enduring material. Mitochondrial diseases are more common than previously recognized and mitochondrial pathophysiology is now a recognized part of many disease processes, including heart disease, cancer, AIDS and diabetes. Mitochondrial Disease and Specialties – Part 2 will focus of the following: Ophthalmic Manifestations, Neuromuscular Features, and Mitochondrial Hearing Loss.

TARGET AUDIENCE

Neurologists, Geneticists, Researchers/Scientists, Pediatrics, Internal Medicine, Nephrologists, Cardiologists, Endocrinologists, Genetic Counselors, Advanced Practice Nurses, Physicians Assistants, RNs, Occupational Therapy, Physical Therapy and Speech-Language Pathology, Nutritional Therapy, Residents/Fellows/Students and patients/families.

ACCREDITATION AND DESIGNATION STATEMENTS

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and United Mitochondrial Disease Foundation. The PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

PeerPoint Medical Education Institute designates this enduring activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Breakdown on Credits Available for Course:

• Ophthalmic Manifestations of Mitochondrial Diseases & What We Can Do About Them = 1
• Neuromuscular Features of Mitochondrial Disorders: Primary Mitochondrial Myopathy (PMM) and Neuropathy = .75
• Hearing impairment in people with mitochondrial disease = .5

Release Date: December 1, 2021 Expiration Date: November 30, 2024

Learning Objectives

Ophthalmic Manifestations of Mitochondrial Diseases & What We Can Do About Them:

• Overview of ophthalmic manifestations as they relate to diagnosing underlying mitochondrial diseases, focusing on those diseases that lead to visual loss and optic atrophy as well as ophthalmoplegia.
• Review of diagnostic approaches and management will be discussed, and clinical cases will be presented.

Neuromuscular Features of Mitochondrial Disorders: Primary Mitochondrial Myopathy (PMM) and Neuropathy:

• Review Neuromuscular involvement in mitochondrial diseases and what is commonly observed
• Illustrate the main clinical features of primary mitochondrial myopathy and of mitochondrial neuropathy
• Review diagnostic approaches and management will be discussed, and clinical cases will be presented

Hearing impairment in people with mitochondrial disease:

• Overview of hearing and review the role of hearing loss in mitochondrial disease
• Review diagnosis and management of mitochondrial hearing loss
• Review novel and emerging therapeutics and technologies for the treatment of mitochondrial hearing loss

Speakers:

• Jane H. Lock, MBBS, MMed, FRANZCO, Royal Perth Hospital – Click Here for Bio
• Michelangelo Mancuso, MD, PhD, University of Pisa, Italy – Click Here for Bio
• Peter Kullar, MRCS, PhD, University of Cambridge, UK - Click Here for Bio